Editas Medicine (EDIT) Non-Current Assets (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Non-Current Assets data on file, last reported at $22.6 million in Q4 2025.

• Quarterly Non-Current Assets fell 56.69% year-over-year to $22.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $114.1 million (down 66.63% YoY) and the FY2025 annual result came in at $22.6 million, down 56.69% from the prior year.
• Non-Current Assets retreated to $22.6 million in Q4 2025 per EDIT's latest filing, from $24.9 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $170.2 million in Q4 2021 and bottomed at $22.6 million in Q4 2025.
• The 5-year median for Non-Current Assets is $122.8 million (2022), against an average of $105.8 million.
• The widest annual swing landed in 2021, when Non-Current Assets surged 255.45%; it then tumbled 71.78% in 2025.
• Tracing EDIT's Non-Current Assets over 5 years: stood at $170.2 million in 2021, then fell by 7.41% to $157.6 million in 2022, then climbed by 0.48% to $158.3 million in 2023, then plunged by 66.98% to $52.3 million in 2024, then slumped by 56.69% to $22.6 million in 2025.
• Per Business Quant, the three latest EDIT Non-Current Assets figures stand at $22.6 million (Q4 2025), $24.9 million (Q3 2025), and $27.8 million (Q2 2025).

Peer Comparison